Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Infliximab and Immunosuppressives for Pediatric Crohn's Disease

NCT05043870 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT05043870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Infliximab and Immunosuppressives for Pediatric Crohn's Disease
Lead sponsor
Children's Hospital of Fudan University
Phase
Phase 4
Overall status
Recruiting
Start date
October 10, 2022
Completion date
December 31, 2026
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, only, crohn disease, immunosuppression, infliximab